• Risk Stratification for SLNB in Melanoma

  • 2022/11/10
  • 再生時間： 26 分
  • ポッドキャスト

Risk Stratification for SLNB in Melanoma

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Although prophylactic lymph node dissections do not improve survival, the prognostic implications of a positive sentinel node and the benefits of removing nodal metastases for loco-regional disease control remain important. There is a strong interest in novel approaches that can improve patients’ selection for sentinel lymphnode biopsies(SLNB) given that 85% of these procedures are negative and non-therapeutic. The host discusses with Dr. Alexander Meves his recent review in Modern Pathology on the role of gene expression profiling in this setting when combined with clinicopathologic parameters.

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Although prophylactic lymph node dissections do not improve survival, the prognostic implications of a positive sentinel node and the benefits of removing nodal metastases for loco-regional disease control remain important. There is a strong interest in novel approaches that can improve patients’ selection for sentinel lymphnode biopsies(SLNB) given that 85% of these procedures are negative and non-therapeutic. The host discusses with Dr. Alexander Meves his recent review in Modern Pathology on the role of gene expression profiling in this setting when combined with clinicopathologic parameters.

Hosted on Acast. See acast.com/privacy for more information.
続きを読む 一部表示

Risk Stratification for SLNB in Melanomaに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。